AI assistant
Sending…
CVS HEALTH Corp — Director's Dealing 2015
Oct 28, 2015
29875_dirs_2015-10-28_77f93cb3-32ae-4ae4-b490-46e772c5b5d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2015-10-27
Reporting Person: Brennan Troyen A (EVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-27 | Common Stock | M | 23603 | $54.53 | Acquired | 85444.059 | Direct |
| 2015-10-27 | Common Stock | S | 23603 | $105.00 | Disposed | 61841.059 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-27 | Stock Option | $54.53 | M | 23603 | Disposed | 2020-04-01 | Common Stock (23603) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 43858 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $45.07 | 2019-04-02 | Common Stock (16637) | 16637 | Direct |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (54550) | 54550 | Direct |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (47937) | 47937 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F3: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F5: Option becomes exercisable in four equal annual installments, commencing 4/1/2016.
More from CVS HEALTH Corp
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3